(Q51134011)

30 March 2018

title

Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery. (English)

1 reference

30 March 2018

1 reference

1 reference

Yimu Zhao

1

1 reference

30 March 2018

Anastasia Korolj

series ordinal

2

1 reference

30 March 2018

Nicole Feric

series ordinal

3

1 reference

30 March 2018

Milica Radisic

series ordinal

4

1 reference

30 March 2018

language of work or name

English

0 references

publication date

25 August 2016

1 reference

30 March 2018

Expert Opinion on Drug Safety

published in

1 reference

30 March 2018

volume

15

1 reference

30 March 2018

issue

11

1 reference

30 March 2018

page(s)

1455-1458

1 reference

30 March 2018

The future of drug safety testing: expanding the view and narrowing the focus

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Strategies and Challenges to Myocardial Replacement Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Microfluidic heart on a chip for higher throughput pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Multielectrode Array (MEA) Assay for Profiling Electrophysiological Drug Effects in Human Stem Cell-Derived Cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Three-dimensional cell culture: a breakthrough in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Cell electrospinning: a novel tool for functionalising fibres, scaffolds and membranes with living cells and other advanced materials for regenerative biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Cell electrospinning: a unique biotechnique for encapsulating living organisms for generating active biological microthreads/scaffolds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Contractile properties of early human embryonic stem cell-derived cardiomyocytes: beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Design and formulation of functional pluripotent stem cell-derived cardiac microtissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

Cell electrospinning cardiac patches for tissue engineering the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14740338.2016.1223624

10.1080/14740338.2016.1223624

21 January 2018

Identifiers

DOI

1 reference

30 March 2018

1 reference

30 March 2018